3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Hematologic Neoplasms
2
Pancreatic Neoplasms
1
Pain, Postoperative
1
Pain, Intractable
1
Neoplasms
1
Neoplasm Metastasis
1
Mucositis
1
Malignant Female Reproductive System Neoplasm
1
Liver Neoplasms
1
Leukemia
1
Kidney Neoplasms
1
Duodenal Neoplasms
1
Digestive System Diseases
1
Carcinoma, Hepatocellular
1
Bone Marrow Failure Disorders
1
Anemia, Aplastic
1
Agnosia
1
Interventions
Saline Solution
7
Dexmedetomidine
5
Bupivacaine
5
Acetaminophen
5
Ropivacaine
4
Lidocaine
4
Morphine
3
Ketamine
3
Control Groups
3
Sodium Chloride
2
Magnesium Sulfate
2
Anesthesia, Spinal
2
salicylhydroxamic acid
1
oxycodone-acetaminophen
1
Transcutaneous Electric Nerve Stimulation
1
Surgical Instruments
1
Respiration
1
Population Groups
1
Oxycodone
1
Ocoxin
1
Nalbuphine
1
Meloxicam
1
Mastectomy, Segmental
1
Ketorolac Tromethamine
1
Ketorolac
1
Injections, Epidural
1
Hydromorphone
1
Hemorrhoidectomy
1
Drainage
1
Dental Occlusion
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pain, Postoperative
×
Hydromorphone
×
1 year
×
Clear all
NCT03715517
2026-02-05
SAFER-L
University of Manitoba
Phase NA
Recruiting
128 enrolled